Investigation Overview
June 3, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Celator Pharmaceuticals Inc (NASDAQ:CPXX), was announced concerning whether the takeover of Celator Pharmaceuticals. by Jazz Pharmaceuticals plc for $30.25 per share is unfair to NASDAQ:CPXX stockholders. The investigation by a law firm concerns whether certain officers and ...
You must register (for free) or login to view the entire investigation.